The manufacturer at the heart of a nationwide formula recall says it has reached a deal on steps necessary to resume production at its shuttered plant

If a court approves the agreement, the company says, it could restart the site within two weeks. It would first resume the production of its specialty metabolic formulas EleCare and … Read More

Loading

Follow by Email
Pinterest
LinkedIn
Share